Study of 0417 Ointment in the Treatment of Atopic Dermatitis

Completed · Phase 3

Conditions studied: Atopic Dermatitis

In brief

The aim of this trial is to assess the efficacy of 0417 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a day, approximately 12 hours apart, for approximately 4 weeks.

Key facts

Study ID

NCT01139450

Run by

Fougera Pharmaceuticals Inc.

People needed

899

Starts

2008-01-01

Expected to finish

2009-08-01

Last updated by the study team

2014-10-09

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Atopic Dermatitis
• Good health with the exception of Atopic Dermatitis
• Percent Body Surface Area minimum requirements

You may not qualify if…

• Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period.
• Subjects who have any systemic or dermatological disorders with the exception of Atopic Dermatitis

Where it is running

• Fougera Pharmaceuticals Inc. — Melville, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.